Status:
COMPLETED
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Lead Sponsor:
Stanford University
Conditions:
Cystinosis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exe...
Detailed Description
High Intensity Interval Training (HIIT) has been frequently used and studied in normal populations. HIIT exercise shows improved exercise capacity with possible benefits to the neuroendocrine system a...
Eligibility Criteria
Inclusion
- \>=18 years -\<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion
- All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional status, development, or bone health unrelated to cystinosis
- Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Key Trial Info
Start Date :
January 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2024
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04071548
Start Date
January 26 2023
End Date
May 15 2024
Last Update
October 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94304